Ledger.Open graph →
SEC Form D · filed May 28, 2015

Cellective BioTherapy, Inc

Offering
$2.5M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
RESEARCH TRIANGLE PARK, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Robert J. Bonczek · Research Triangle Park, NCExec · Director · PromoterMarshall C. Johnson · Wayzata, MNExec · Director · PromoterThomas F. Tedder · Research Triangle Park, NCExec · Director · PromoterAbraham Chu · Houston, TXExec · Director · PromoterThomas F. Tedder · Research Triangle Park, NCExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗